A novel dual promoter DNA vaccine induces CD8+ response against Toxoplasma gondii sporozoite specific surface protein “SporoSAG” through non-apoptotic cells-Reference-Cited by-同舟云学术

A novel dual promoter DNA vaccine induces CD8+ response against Toxoplasma gondii sporozoite specific surface protein “SporoSAG” through non-apoptotic cells

Published:2014 Issue: Volume:3 Page:81-88
ISSN:1879-4378
Container-title:Trials in Vaccinology
language:en
Short-container-title:Trials in Vaccinology

Author:

Gülçe İz Sultan,Döşkaya Mert,Caner Ayşe,Döşkaya Aysu Değirmenci,Rodriguez Fernando,Gürüz Yüksel,Gürhan S. İsmet Deliloğlu

Funder

The Scientific and Technological Research Council of Turkey

Ege University Science and Technology Center, Turkey

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Microbiology

Reference61 articles.

1. Toxoplasmosis;Montoya;Lancet,2004

2. Toxoplasma gondii, The Model Apicomplexan: Perspectives and Methods;Weiss,2007

3. Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey;Ertug;BMC Public Health,2005

4. A four-year investigation of the seropositivity of Toxoplasma gondii in our hospital;Kuk;Turkiye Parazitol. Derg.,2007

5. Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey;Harma;J. Egypt Soc. Parasitol.,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis;Vaccine;2024-10

2. Genetic immunization against toxoplasmosis: A review article;Microbial Pathogenesis;2021-06

3. Current State of the Art in DNA Vaccine Delivery and Molecular Adjuvants: Bcl-xL Anti-Apoptotic Protein as a Molecular Adjuvant;Immune Response Activation and Immunomodulation;2019-04-17

4. Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine model;Trials in Vaccinology;2016